BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,661,000 | -39.2% | 26,000 | +2.0% | 0.02% | -32.1% |
Q4 2021 | $2,731,000 | +68.8% | 25,500 | +26.2% | 0.03% | +7.7% |
Q4 2019 | $1,618,000 | +39.4% | 20,200 | +27.8% | 0.03% | +18.2% |
Q3 2019 | $1,161,000 | -20.6% | 15,800 | +1.9% | 0.02% | -12.0% |
Q2 2019 | $1,462,000 | – | 15,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |